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Aim To estimate global morbidity from acute bacterial 
meningitis in children.
Methods We conducted a systematic review of the PubMed 
and Scopus databases to identify both community-based 
and hospital registry-based studies that could be useful in 
estimation of the global morbidity from bacterial meningitis 
in children. We were primarily interested in the availability 
and quality of the information on incidence rates and case-
fatality rates. We assessed the impact of the year of study, 
study design, study setting, the duration of study, and sam-
ple size on reported incidence values, and also any associa-
tion between incidence and case-fatality rate. We also cat-
egorized the studies by 6 World Health Organization regions 
and analyzed the plausibility of estimates derived from the 
current evidence using median and inter-quartile range of 
the available reports in each region.
Results We found 71 studies that met the inclusion criteria. 
The only two significant associations between the report-
ed incidence and studied covariates were the negative cor-
relation between the incidence and sample size (P < 0.001) 
and positive correlation between incidence and case-fatal-
ity rate (P < 0.001). The median incidence per 100 000 child-
years was highest in the African region – 143.6 (interquartile 
range [IQR] 115.6-174.6), followed by Western Pacific region 
with 42.9 (12.4-83.4), the Eastern Mediterranean region with 
34.3 (9.9-42.0), South East Asia with 26.8 (21.0-60.3), Europe 
with 20.8 (16.2-29.7), and American region with 16.6 (10.3-
33.7). The median case-fatality rate was also highest in the 
African region (31.3%). Globally, the median incidence for all 
71 studies was 34.0 (16.0-88.0) per 100 000 child-years, with 
a median case-fatality rate of 14.4% (5.3%-26.2%).
Conclusions Our study showed that there was now suffi-
cient evidence to generate improved and internally consis-
tent estimates of the global burden of acute bacterial men-
ingitis in children. Although some of our region-specific 
estimates are very uncertain due to scarcity of data from the 
corresponding regions, the estimates of morbidity and case-
fatality from childhood bacterial meningitis derived from this 
study are consistent with mortality estimates derived from 
multi-cause mortality studies. Both lines of evidence imply 
that bacterial meningitis is a cause of 2% of all child deaths.
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Meningitis is an infectious disease affecting the brain mem-
brane and spinal cord (1). Globally, bacterial meningitis is 
the most severe type of meningitis, mainly caused by a tri-
ad of species Neisseria meningitidis, Streptocccus pneumo-
nia, and Haemophilus influenzae (2). While viral meningitis 
is usually a self-limiting disease with good prognosis, bac-
terial meningitis is potentially fatal, requiring urgent medi-
cal assistance and management with antibiotics treatment 
(3). Various estimates of the burden of bacterial meningitis 
have been proposed to date, but they have mainly focused 
on mortality (4), long-term sequels (5), or etiology-specific 
morbidity and mortality (6-8).
Interestingly, there have been no comprehensive attempts 
to estimate the overall global burden of bacterial meningi-
tis in children. This is not surprising, because such attempt 
would face almost insurmountable methodological chal-
lenges. First, there is a problem with case definition of “bac-
terial meningitis” (9). In low resource settings, where the 
problem is most common, many children may present with 
“purulent meningitis,” whose cause is highly likely bacterial, 
but laboratory capacity may not be sufficient to isolate the 
causal agent and confirm the diagnosis. This leads to a dis-
crepancy between morbidity burden estimates based on 
“all purulent meningitis” and “laboratory confirmed menin-
gitis” – the latter always being lower than the former, but 
to a different extent in different contexts (10). The second 
large methodological obstacle is the problem of “meningi-
tis belt.” The meningitis belt is the band of countries extend-
ing from Senegal to Ethiopia, characterized by semi-arid 
climate, dry seasons, and dusty winds, with seasonal out-
breaks of meningococcal meningitis being recorded since 
the beginning of the 20th century (11). The problem with 
these epidemics is that they can last for several years and 
dramatically change the importance of meningococcus in 
comparison to the other two bacterial agents (S. pneumo-
niae and H. influenzae) both regionally and globally (11). This 
makes it difficult to express the “burden of disease” for any 
given year, because it will be very different in intra-epidem-
ic and inter-epidemic years. Moreover, the extent of vaccine 
coverage against N. meningitidis, S. pneumoniae and H. influ-
enzae is changing the burden rapidly and rather dramatical-
ly in many places, rendering the scarce evidence from be-
fore the period of vaccination rather useless and indicates 
a need of revision (12). Finally, the emergence of HIV/AIDS 
pandemic led to a substantial number of infected children, 
whose resistance to other infections is impaired and they 
present a specific category of population in which the rates 
of incidence and case-fatality rates may be very different 
from those in other children (13).
It is apparent that meningitis continues to contribute sig-
nificantly to global mortality and morbidity, but the im-
pact of the efforts to control it is difficult to estimate given 
that we do not have comprehensive estimates of global 
morbidity patterns. Understanding the global morbid-
ity from bacterial meningitis would be useful because 
it would also help to validate the existing mortality esti-
mates through application of appropriate case-fatality 
rates. The purpose of the present study is to provide a 
comprehensive assessment of the evidence that is avail-
able for estimating the global morbidity from acute bac-
terial meningitis in children globally. We will also propose 
initial, robust estimates of the burden, with suggestions 
on the possible ways to address the methodological chal-
lenges in future studies.
MethOdS
data sources – search strategy and selection criteria
It is essential to formulate a case definition for meningi-
tis given that the clinical presentation is often non-specific 
(Supplementary Text 1). Therefore, we only included stud-
ies that aimed to confirm suspected meningitis cases with 
the analysis of cerebrospinal fluid (CSF) (Supplementary 
Text 2) to eliminate the potential for diagnostic subjectiv-
ity and allow comparison. In addition, ICD-10 codes were 
noted, with those applicable to meningitis used in making 
a decision on study inclusion (Supplementary Text 3).
The search strategy was defined with the aim to capture all 
possibly informative studies, while excluding the majority 
of studies that were not relevant. No studies were exclud-
ed based on language of publication, although for studies 
not published in English information was extracted from 
abstracts only.
The search strategy used was:
“meningitis AND (incidence OR prevalence OR mortality 
OR morbidity OR sequela* OR case fatality OR risk factor*)”
and was applied as a free search in title/abstract field in 
both the PubMed and Scopus databases in the period be-
tween January 1, 1980 and December 31, 2010. The search 
was limited to studies in humans only (Figure 1).
The full text of the studies was retrieved wherever possible. 
The following were applied as inclusion criteria required 
for each study before proceeding to data extraction:
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(i) Incidence, prevalence, mortality or case fatality rate for 
meningitis;
(ii) Defined denominator of the study population (commu-
nity or population based studies were preferred, but hospi-
tal-based registries of sufficient quality and with a defined 
reference population were also retained);
(iii) Clinical confirmation of meningitis by CSF culture;
(iv) Minimum study period of one year (or multiples of 
one year);
(v) At least 10 cases of confirmed acute bacterial men-
ingitis;
FIguRe 1. Flowchart showing the process of literature search. ABM – acute bacterial meningitis.
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(vi) Age groups defined as 0-4 years, because in the studies 
that used age groups 0-2 years and/or 0-14 years, the over-
all incidence would be substantially different;
(vii) Any further methodological ambiguities about how 
the study was conducted, or systematic error in the design 
of research that could affect the final results of the study;
The data extracted from studies was entered into a data-
base for further analysis (Supplementary Table 1).
The titles returned by the first search were further browsed 
by two independent researchers (IL and RF), who selected 
the final set of studies that met all inclusion criteria. Wherev-
er two researchers disagreed about inclusion or exclusion of 
certain studies, disagreement was resolved by seeking the 
opinion from a third party (IR) who resolved any disputes.
data arrangement
The incidence rate of meningitis in children was deter-
mined using the following formula:
I = (number of new cases ×100,000) / (population at 
risk × number of years of follow-up)
The resulting incidence was not age-standardized to the 
level of individual countries or regions, because of the lack 
of data on the level of individual studies or registries to en-
able direct age standardization using the age-specific in-
cidence of five-year age groups, which was a prerequisite 
for the implementation of such standardization and which 
would represent the ideal design. However, in all studies 
incidence was expressed in a standard way, as the number 
of new cases per year per 100 000 person-years.
Case-fatality rate was expressed in all studies as a percent-
age, and its value was calculated as:
CFR = (number of deaths from meningitis) / (number of 
cases of meningitis)
Statistical analysis
The association between the dependent variable (inci-
dence rate) and its independent predictors was studied in 
the following way:
(i) A regression analysis was performed to analyze the rela-
tionship between the design of study (prospective or ret-
rospective) and the reported incidence rates and the rela-
tionship between the study setting (community-based or 
hospital registry) and the reported incidence rates. In this 
way, we were primarily interested whether the lack of ac-
cess to hospitals would affect the reports based on hospi-
tal registers.
A regression analysis based on linear, “power,” logarithmic, 
and/or exponential function was performed to analyze:
(ii) the relationship between the year of study and the re-
ported incidence rates, to check for any apparent time 
trends. The results were shown as the “best fit” equation 
showing dependence of incidence rate on the year of the 
study and the value of R2 (eg, the proportion of the total 
variability in the dependent variable explained by the pre-
dictor variable).
(iii) the relationship between the duration of the study (in 
months) and incidence rates for acute bacterial meningi-
tis. This analysis was primarily important to check for the 
possible presence of the “Hawthorne effect” – ie, indirect 
positive effects of carrying out the study in the population, 
leading to improved health indicators over time.
(iv) the relationship between sample size and the report-
ed incidence rates. This analysis is important as it can de-
tect “publication bias.” Generally, with the increasing sam-
ple sizes, the incidence rates should converge to the real 
value, while in smaller studies there is “scattering” in both 
directions. Another possible problem is that larger studies 
may report lower incidence rates because of difficulties in 
monitoring a very large population, which results in under-
reporting.
(v) whether the incidence rate may itself serve as a predic-
tor, with case-fatality rate as a dependent variable.
The statistical significance of the association was ex-
pressed as a P value and values lower than 0.01 were con-
sidered significant. All the analyses were conducted using 
Microsoft Excel software licensed to the University of Ed-
inburgh.
ReSuLtS
Seventy-one retained studies met minimum require-
ments for inclusion (Table 1). Most studies were avail-
able from the African Region – 21 in total, 14 from Eu-
rope, 13 from Western Pacific region, 11 from the 
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Americas, 7 from the Eastern Mediterranean region, and 5 
from South East Asia. The median incidence was highest 
in the African region, where the “meningitis belt” is locat-
ed – 143.6 new cases per 100 000 child-years (IQR 115.6-
174.6), followed by Western Pacific region with 42.9 (12.4-
83.4) and the Eastern Mediterranean region with 34.3 
(9.9-42.0). The median case-fatality rate was also highest 
in the African region (31.3%). Globally, the median inci-
dence rate for all 71 studies was 34.0 (16.0-88.0) of new 
cases per 100 000 child-years, with a median case-fatality 
rate of 14.4% (5.3%-26.2%).
In order to further discuss various effects of obtained co-
variates on observed results we conducted several analy-
ses of the association between the criterion variable (inci-
dence rate) and the variables associated with the design 
of the research. In the first such test, the relationship be-
tween the study year and the reported incidence rates was 
explored for all types of confirmed acute bacterial menin-
gitis (Figure 2), to investigate whether there was a grow-
ing or a declining trend in incidence over time. Although 
it appears that the incidence increased over the two de-
cades from about 30 to about 40 new cases per 100 000 
person-years, this approximation explains only about 2% 
of the observed variability in the system. The median inci-
dence reported in prospective studies was about 75 cases 
per 100 000 child-years and in retrospective about 45 cases 
per 100 000 child-years (Figure 3), which indicates that ret-
rospective studies generally report lower incidence than 
prospective studies, but this difference was not significant. 
The analysis of influence of study setting on the results did 
not show any systematic influence (Figure 4). Moreover, we 
analyzed the effect of the study duration on reported inci-
FIguRe 2. Analysis of the relationship between the year of 
study and the reported incidence rates for acute bacterial 
meningitis.
FIguRe 3. Analysis of the relationship between study design 
(prospective/retrospective study) and incidence rates for acute 
bacterial meningitis.
tABLe 1. Medians of incidence and lethality rates of acute bacterial meningitis in children under 5 y of age by World health Organiza-




Median incidence rate 









Africa 21 143.6 115.6-174.6 43.4 311.0 0.313 0.262-0.317 0.203 0.388
Americas 11  16.6  10.3-33.7  8.5  59.6 0.153 0.141-0.207 0.092 0.396
Eastern 
Mediterranean
 7  34.3   9.9-42.0  3.1  43.0 0.063 0.052-0.105 0.041 0.146
Europe 14  20.8  16.2-29.7  8.9  36.6 0.081 0.054-0.107 0.053 0.200
South-East 
Asia
 5  26.8  21.0-60.3 14.2  66.8 0.037 0.033-0.041 0.029 0.045
Western 
Pacific
13  42.9  12.4-83.4  5.3 149.6 0.078 0.048-0.117 0.033 0.184
World 71  34.0  16.0-88.0  3.1 311.0 0.144 0.053-0.262 0.029 0.396
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dence rates (Figure 5). This analysis aims to detect the pres-
ence of the “Hawthorne’s effect”. Our study did not show 
any support for the existence of such effect.
We also explored the relationship between sample size 
and reported incidence (Figure 6). This analysis is very im-
portant, because it can demonstrate the existence of the 
“positive publication bias.” Generally, increased sample size 
leads to more credible results that begin to converge to 
the true value, while smaller studies can show greater or 
smaller estimates “scattered” in both directions around 
the true values, because there is an increased likelihood 
of false-positive results in smaller samples. In this study, 
there was a significant reduction in incidence with increas-
ing sample size (with R2 of 44.3%, P < 0.0001). This finding 
could perhaps be partly explained by difficulties in sys-
tematic prospective follow-up of all patients in very large 
studies, resulting in decreased reporting of the cases and 
smaller incidence. Finally, when the dependent variable 
was changed, the incidence became a predictor variable, 
while the case-fatality rate became a new criterion variable 
– because time sequence between these two variables re-
quires such approach (Figure 7). With the increase in the 
incidence rate, there was a strong rise in case-fatality rate, 
too, but only to the extent of about 30%, when the “satura-
tion” occurs and lethality remains approximately the same 
thereafter, regardless of further increase in incidence.
dIScuSSION
This study provides new insights relevant to health poli-
cy development toward the fight against acute bacterial 
FIguRe 4. Analysis of the relationship between study setting 
(community based vs hospital registers) and incidence rates 
for acute bacterial meningitis.
FIguRe 5. Analysis of the relationship between the duration of 
the study (expressed in months) and incidence rates for acute 
bacterial meningitis.
FIguRe 6. Analysis of the relationship between sample size 
and incidence rates for acute bacterial meningitis.
FIguRe 7. Analysis of the relationship between the incidence 
rates and the case fatality rates for acute bacterial meningitis.
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meningitis in preschool children. It assesses the available 
evidence in a systematic way to demonstrate that there is 
now a sufficient number of studies to allow a robust initial 
estimation of the global burden of meningitis. This is be-
coming possible due to a sufficient number of studies (71 
papers) that implemented comparable methods and pro-
vided results that were consistent with each other.
In this study, we did not attempt to overcome the main ob-
stacles to computing the burden of meningitis at the glob-
al level – the problem of etiologically unaccounted cases 
of purulent meningitis, multi-year epidemics in the menin-
gitis belt, correction of the reported results for vaccination 
coverage, or accounting for the effect of HIV/AIDS positiv-
ity. The aim here was to simply present an initial, crude as-
sessment of the burden based on the number of observed 
cases that were etiologically confirmed, in order to pres-
ent a credible lower limit to the estimates of global and re-
gional burden of childhood acute bacterial meningitis and 
explore whether it yielded plausible results that were com-
patible with previous estimates. Further adjustments and 
etiology-specific estimates are beyond the scope of this ar-
ticle, but we plan to continue our efforts and address them 
with increasing amount of appropriate evidence.
Accurate estimation of global, regional, and national bur-
den meningitis in children will remain difficult for a number 
of reasons. The incidence of meningitis in the population 
generally can be adequately estimated only by longitu-
dinal studies in the community. Such studies are rare in 
developing countries, where the burden of meningitis is 
the greatest, partly because such studies require a great-
er commitment of researchers and investors over a longer 
period of time. Due to the seasonal nature of meningitis 
frequency, which has different peaks of viral and bacterial 
outbreaks at different times, it is necessary to carry out re-
search that would measure the frequency throughout the 
entire calendar year (or multiples of 12-month period). This 
problem is typical for many infectious diseases, such as in-
fant diarrhea, pneumonia, or flu, but meningitis has addi-
tional specificity that is almost impossible to resolve meth-
odologically, ie, that it can last for several years, for example 
in the “meningitis belt” in Africa. In these areas, a proper 
assessment of the epidemiological characteristics of the 
disease would require studies that would take a minimum 
of 10 years or more, so that a proper insight into the mor-
bidity and mortality in the inter-epidemic and intra-epi-
demic periods could be obtained. This preliminary study 
that assessed the availability and quality of the current 
evidence and provided the first robust estimates of 
the morbidity from bacterial meningitis in children should 
therefore be amended in the future by adequate adjust-
ments. Those adjustments would need to take into ac-
count the multi-year epidemics in the “meningitis belt” is-
sue, HIV/AIDS positivity, and vaccine coverage.
In addition to those methodological requirements, a fur-
ther source of uncertainty in measuring the frequency of 
meningitis in children in the community results from the 
case definition of meningitis, as well as the adequacy of 
the application of this definition by the assessors to make 
a diagnosis. There is no definition of clinical symptoms of 
the disease that is perfectly correct and distinguishes cases 
of meningitis from other possible diseases with 100% va-
lidity. Therefore, any study of the incidence of meningitis 
in the community would not measure the meningitis as a 
disease, but rather the number of children who test posi-
tive for the chosen definition of a case of meningitis. The 
definition of a case can be based on a number of clinical 
signs and symptoms, and diagnostic procedures, as well 
as on laboratory isolation of pathogens from cerebrospi-
nal fluid. Depending on the combination of sensitivity and 
specificity of selected case definitions of meningitis, the 
burden of meningitis in the community can be over- or 
underestimated.
In this study, we separated all retrieved studies according to 
WHO regions: Africa (AFRO), the Americas (AMRO), Eastern 
Mediterranean region (EMRO), Europe (EURO), Southeast 
Asia (SEARO), and Western Pacific (WPRO). We calculated 
regional burden of morbidity and appropriate confidence 
intervals as the median of all standardized estimates (and 
inter-quartile range, IQR) multiplied by the size of the pop-
ulation of children aged 0-4 years in the year 2010. Esti-
mates were based on 71 independent studies published 
between 1980 and 2010. Finally, we multiplied the burden 
calculated as above with median reported case-fatality 
rate for each region to estimate the total number of deaths 
and compare it to previous estimates, using UN’s popula-
tion projections for 2010 (14). Concordance with previous 
studies means that all the presently available evidence on 
the epidemiology of acute bacterial meningitis in children 
is beginning to converge toward a consistent picture on 
the extent and significance of this devastating disease in 
the world today. This justifies further efforts to refine eti-
ology-specific estimates and work toward generating na-
tional-level estimates.
Moreover, it is important to note that there is a considerable 
discrepancy between the estimates based on the clinical 
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picture of purulent meningitis and estimates based on lab-
oratory-confirmed bacterial meningitis. The former are like-
ly to overestimate the actual size of the problem because 
they may involve complicated cases of meningitis that was 
primarily viral in etiology. The latter probably underestimate 
the true magnitude of the problem because they fail to iso-
late and prove the cause in a proportion of all cases due 
to problems related to laboratory analysis and variability of 
pathogens in poorly developed regions, where the burden 
of disease is greatest. Our study implies that confirmed cas-
es of bacterial meningitis account for about 61.5% of the 
burden of all purulent meningitis globally.
Regardless of the aforementioned weakness and uncertain-
ties inherent to this preliminary study, the main strength of 
this study is that it used the two most accessible sources of 
data – PubMed and Scopus – to demonstrate that there is 
now sufficient evidence to generate improved and inter-
nally consistent estimates of the global burden of acute 
bacterial meningitis in children. We only used PubMed and 
Scopus because we assumed that those two sources would 
account for a large majority of studies that would satisfy our 
stringent inclusion criteria, and this study was of an explor-
atory character and we did not aim to be fully comprehen-
sive at this stage of the analysis. Some of our region-specif-
ic estimates are still very uncertain due to scarcity of data 
from the corresponding regions, which may in some cases 
lead to rather implausible regional estimates (such as case-
fatality rates in Americas, for example, which seem rather 
high in comparison to other, less developed regions). How-
ever, the main positive conclusion is that the estimates of 
morbidity and case-fatality from childhood bacterial men-
ingitis derived from this study are consistent with mortality 
estimates derived from multi-cause mortality studies. Both 
lines of evidence imply that bacterial meningitis is a cause 
of 2% of all child deaths, which is de facto a replication of 
the result obtained through an entirely independent line of 
evidence. This gives us assurance that the global estimates 
of mortality from bacterial meningitis are plausible and that 
this new estimate of morbidity is rater robust, too.
According to this study, if case-fatality rates were applied 
to incidence rates, then the total number of deaths from 
meningitis in children younger than 5 years annually in the 
world would exceed 113 000 children, which is 1.64% of 
all child deaths in the world in 2010. This number is sup-
portive of the estimates of Child Health Epidemiology Ref-
erence Group (CHERG), which amounted to 2% and were 
based on an entirely different set of evidence compared to 
our present study, using only information from multi-cause 
mortality studies (4). Thus, this study indicates that there is 
an increasing consistency between the current estimate of 
the global burden of morbidity from bacterial meningitis 
and the estimate of mortality.
This study provided the first robust estimate of the global 
and regional burden of acute bacterial meningitis. It also 
confirmed that the current estimate of the mortality from 
meningitis based on multi-cause mortality studies is likely 
to be accurate. The presented evidence should allow fur-
ther and improved estimates, and also planning and guide-
lines for health-related activities for bacterial meningitis in 
preschool children globally and regionally, with the aim of 
combating morbidity and mortality from this disease. It is 
clear that the increase in pneumococcal, Hib, and menin-
gococcal vaccination, which are currently carried out by 
the GAVI Alliance and UNICEF (15,16) will contribute to a 
further significant reduction of morbidity and mortality 
from bacterial meningitis in children all over the world.
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